Company: DNLI
Filing Date: 2025-04-17
Form Type: DEF 14A
Source: 0001714899-25-000087
Chunk: 54

Company: Denali Therapeutics Inc.
Filing Date: 2025-04-17
Form: DEF 14A
Chunk 54
---
 of the Code. If any of the payments or benefits provided for under the Severance Plan or otherwise payable to a named executive officer would constitute “parachute payments” within the meaning of Section 280G of the Code and could be subject to the related excise tax, he or she would receive either full payment of such payments and benefits or such lesser amount that would cause no portion of the payments and benefits being subject to the excise tax, whichever results in the greater after-tax benefits to our named executive officer.

Compensation Recovery (“Clawback”) Policy

In June 2023, the SEC approved the Nasdaq’s proposed rules implementing the incentive-based compensation recovery provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”), which require listed companies to develop and implement a policy providing for the recovery of erroneously awarded incentive-based compensation received by current or former executive officers and to satisfy related disclosure obligations.

On November 13, 2023 and disclosed as an exhibit to Form 10-K filed with the SEC on February 28, 2024, we adopted our Compensation Recovery Policy, which applies to all covered employees to reflect and comply with these new requirements. Our policy provides that the Company is required to recover certain erroneously paid incentive-based compensation, including cash incentive or performance-vesting equity compensation, of its current and former executive officers in the event the Company is required to prepare a qualifying accounting restatement.

<div align='center'>-40-</div>

Summary Compensation Table For Fiscal Year s 2022, 2023 and 2024

The following table provides information regarding the compensation of our named executive officers during the years ended December 31, 2022, 2023 and 2024.

| Name and Principal Position                         |     | Year |     | Salary |         |     | Bonus(1) |         |     | Stock Awards(2) |           |     | Option    
 Awards(3) |           |     | All Other       
 Compensation(4) |        |     | Total |           |
|:----------------------------------------------------|:----|-----:|:----|:-------|--------:|:----|:---------|--------:|:----|:----------------|----------:|:----|:----------|----------:|:----|:----------------|-------:|:----|:------|----------:|
| Ryan J. Watts, Ph.D.                                |     | 2024 |     | $      | 690,